Distribution of SALT Scores with Ritlecitinib Treatment up to 24 months from the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. s465, 2024. DOI: 10.25251/skin.8.supp.465. Disponível em: https://skin.dermsquared.com/skin/article/view/3084. Acesso em: 26 oct. 2025.